PMID: 9420288Jan 7, 1998Paper
Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma
Journal of Virology
R M DiazR G Vile
Abstract
To generate transcriptionally targeted vectors, tissue-specific elements of the human tyrosinase promoter were exchanged with corresponding viral elements in the Moloney murine leukemia virus long terminal repeat (LTR). From these experiments, a vesicular stomatitis virus type G pseudotyped, hybrid LTR vector that contained three tyrosinase enhancer elements and gave high-level, tightly tissue-specific expression at high titers (3 x 10(7) CFU/ml) was constructed.
References
Jan 1, 1992·Annual Review of Cell Biology·J M Whitcomb, S H Hughes
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T D PalmerA D Miller
Dec 1, 1990·Journal of Virology·G Feuer, H Fan
Jan 1, 1990·Current Topics in Microbiology and Immunology·J Majors
Jan 1, 1989·Journal of Virology·A L BoralJ Lenz
Feb 1, 1989·Molecular and Cellular Biology·J R FlanaganA S Khan
Sep 1, 1985·Journal of Virology·C A RosenM W Cloyd
Apr 1, 1987·Journal of Virology·M K ShortJ Lenz
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S F YuE Gilboa
Dec 1, 1995·Journal of Virology·F L CossetM K Collins
Jun 1, 1995·Human Gene Therapy·G FerrariF Mavilio
Sep 1, 1995·Nature Medicine·C Wilson, M A Kay
Sep 1, 1995·Nature Medicine·Y YangJ M Wilson
Jan 1, 1995·British Medical Bulletin·R G Vile, S J Russell
Feb 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N Miller, R Vile
Jun 1, 1994·Human Gene Therapy·L A CoutureR A Morgan
Dec 1, 1994·Molecular and Cellular Biology·N J BentleyC R Goding
Dec 1, 1994·Molecular and Cellular Biology·K YasumotoS Shibahara
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Apr 1, 1993·Human Gene Therapy·C A Richards, B E Huber
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J C BurnsJ K Yee
Dec 1, 1995·Virology·R G VileS J Russell
Oct 18, 1996·Science·J R BischoffF McCormick
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·D S OryR C Mulligan
Dec 1, 1996·Molecular Biotechnology·W Walther, U Stein
❮ Previous
Next ❯
Citations
Mar 1, 2000·Gene Therapy·G MavriaC D Porter
Nov 18, 2000·Gene Therapy·D NègreF L Cosset
Jul 5, 2001·Gene Therapy·L EmiliusenR Vile
Feb 24, 2001·The Journal of Gene Medicine·P Y Lam, X O Breakefield
Mar 5, 2002·Nature Biotechnology·John ChesterRichard Vile
Nov 20, 2002·Journal of Virology·Christopher R LoggNoriyuki Kasahara
Aug 20, 2003·Nature Medicine·Vy PhanRichard Vile
Jun 8, 2004·Pediatric Research·Sabine SteffensChristof M Kramm
Apr 21, 2006·Gene Therapy·T KottkeR Vile
Oct 31, 2014·Gene Therapy·Y-H LaiC-K Tai
Jun 2, 2001·Human Gene Therapy·C R LoggN Kasahara
Dec 29, 2004·FEBS Letters·Rosanna Martinelli, Vincenzo De Simone
Aug 10, 2004·Nature Biotechnology·Gregory A DanielsRichard G Vile
Mar 5, 2004·Gene Therapy·T B RichardsonC D Porter
Oct 1, 2020·Viruses·Aneta PlutaRenée N Douville
Sep 12, 2002·Gene Therapy·S GhazizadehL B Taichman
Jan 15, 2004·Journal of Virology·Juraj HlavatyMatthias Renner
Dec 22, 2007·Experimental Dermatology·Jürgen EberleHenry Fechner
Nov 16, 2004·The Journal of Gene Medicine·Georgia MavriaColin D Porter
Jul 1, 2006·Journal of Virology·Christian MetzlDaniel Portsmouth
Sep 20, 2005·Nature Medicine·Caroline ColeRichard G Vile
Oct 18, 2005·Journal of Cellular Biochemistry·Daniel J Selski, Denis R Clohisy
Nov 18, 2000·Gene Therapy·R M DiazR G Vile
Nov 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Luisa BarzonGiorgio Palù
Mar 21, 2003·Gene Therapy·I PeterS Hemmi
Feb 5, 2005·Cancer Gene Therapy·Carsten FingerKlaus Cichutek
Dec 20, 2005·The Journal of Pathology·Lawrence S YoungVivien Mautner
Aug 7, 2002·Human Gene Therapy·Kevin HarringtonRichard Vile
May 23, 2006·Pharmaceutical Research·Ethlinn V B van GaalEnrico Mastrobattista
Dec 19, 2002·Cancer Gene Therapy·Sounkary K SollyDavid Klatzmann
May 14, 2005·Cancer Gene Therapy·Trine LillehammerOlav Engebraaten
Nov 13, 1999·Journal of Virology·U JägerC D Porter
Jan 2, 2021·Pathogens·Aneta PlutaCésar N Cortés-Rubio
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kei HiraokaNoriyuki Kasahara
Feb 24, 2001·The Journal of Gene Medicine·J C Zhao-EmonetD Klatzmann
May 18, 2000·Reviews in Medical Virology·G PalùM Pizzato
Nov 18, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·G Daly, Y Chernajovsky
Nov 10, 2000·Advanced Drug Delivery Reviews·K J HarringtonR G Vile
May 3, 2000·Kidney International·V Kon, I Ichikawa
Dec 9, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dong-Youn HwangKwang-Soo Kim
May 26, 2005·Biochimica Et Biophysica Acta·G D HallJ D Chester
Aug 9, 2021·Virology·Sílvio R ConsonniMarcio C Bajgelman
Apr 11, 2006·Virology Journal·Diana E JaaloukJacques Galipeau
❮ Previous
Next ❯
Related Concepts
Related Feeds
CREs: Gene & Cell Therapy
Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.
Related Papers
Molecular and Cellular Biology
D Reisman, V Rotter
Journal of Immunological Methods
R W OverellK H Grabstein
Virology
J F EngelhardtP M Pitha
Journal of Virology
N V SomiaI M Verma